This document discusses pharmacokinetics and provides details about absorption, distribution, and bioavailability of drugs. It defines key pharmacokinetic terms and describes factors that influence absorption such as solubility, concentration, route of administration, and mechanisms of absorption including passive diffusion, active transport, and pinocytosis. Membrane permeability and drug properties like pH and lipid solubility are discussed. The document also covers volume of distribution, plasma protein binding, tissue storage, and barriers to drug distribution like the blood-brain barrier.
The slides describe concept of distribution, Volume of distribution, factors affecting volume of distribution and the barriers to distribution. Blood brain barrier and placental barrier.
The slides describe concept of distribution, Volume of distribution, factors affecting volume of distribution and the barriers to distribution. Blood brain barrier and placental barrier.
A presentation given by a group of students of Faculty of Pharmacy, University of Dhaka, Bangladesh.
This presentation discussed with different physiolgical factors of drug absorption, structure of membrane the drug crosses, different transport mechanism etc
A brief presentation about the transport of drugs across the cell membrane including the many mechanisms and various transporters and a brief overview of the ABC and SLC superfamily of transporters.
A presentation given by a group of students of Faculty of Pharmacy, University of Dhaka, Bangladesh.
This presentation discussed with different physiolgical factors of drug absorption, structure of membrane the drug crosses, different transport mechanism etc
A brief presentation about the transport of drugs across the cell membrane including the many mechanisms and various transporters and a brief overview of the ABC and SLC superfamily of transporters.
Pharmacokinetics is the study of the movement of drug molecules in the body. It includes absorption, distribution, metabolism, and excretion of drugs. Pharmacokinetics is the study of what happens to drugs once they enter the body (the movement of the drugs into, within, and out of the body). For a drug to produce its specific response, it should be present in adequate concentrations at the site of action. This depends on various factors apart from the dose.
Four pharmacokinetic properties determine the onset, intensity, and the duration of drug action (Figure 1.6.1):
• Absorption: First, absorption from the site of administration permits entry of the drug (either directly or indirectly) into plasma.
• Distribution: Second, the drug may then reversibly leave the bloodstream and distribute it into the interstitial and intracellular fluids.
• Metabolism: Third, the drug may be biotransformed by metabolism by the liver or other tissues.
• Elimination: Finally, the drug and its metabolites are eliminated from the body in urine, bile, or feces.
In short, pharmacokinetics means what the body does to the drug.
The Indian Dental Academy is the Leader in continuing dental education , training dentists in all aspects of dentistry and
offering a wide range of dental certified courses in different formats.
Presentation covers the basics of pharmacokinetic. Mechanism for the transport of drug molecule. Absorption, factors affecting on absorption of drugs. Concept of bioavailability. Distribution, plasma protein binding, tissue binding, barriers.
Introduction to Medicinal Chemistry, History and development of medicinal chemistry, Physicochemical properties in relation to biological action Ionization, Solubility, Partition Coefficient, Hydrogen bonding, Protein binding, Chelation, Bioisosterism, Optical and Geometrical isomerism, Drug metabolism Drug metabolism principles- Phase I and Phase II. Factors affecting drug metabolism including stereo chemical aspects
Stability Testing During Product DevelopmentAl Riyad Hasan
Stability Testing During Product Development:
Practical conduct of stability testing
Presentation and recording of results
Stability data handling and estimation of shelf life
Package Labelling
. Introduction to Pharmacology Course Title: Pharmacology I Course No.: PHAR 2113 Prepared by: Biswajit Biswas Reference: Goodman & Gilman’s Manual of Pharmacology and Therapeutics
2. Pharmacology Greek pharmakon : "drug“ ; and logia : "the study of“. Greek: Pharmacon (Drug) Modern Latin: Pharmacologia 18th Century: Pharmacology The branch of medicine concerned with the uses, effects, and modes of action of drugs.
3. Historic development of pharmacology Worlds oldest pharmacology - from India and China Materia medica (2735 B.C.) by Pan Tsao- contained mainly Plant and metal with few animal products Ayurveda - described by Charaka accordig to Rigveda (3000 B.C.) - includes 300 vegetable drugs , classified into 50 groups according to their effects on symptoms. Papyrus (1500 B.C.) discovered by Eber -700 drugs Modern medicine (from 450 B.C.) by Hippocrates- concept of disease as a pathologic process and organize pharmacology on the basis of observation, analysis and deduction.- use simple and efficacious drugs.
4. Allopathay (James gregory, 1753-1821) -treatment without any rational basis- use symptomatic treatment with obnoxious remedis. Homeopathy (Hanneman, 19th century)-
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
2. Pharmacokinetics
1. Refers to
i) movement of drug in the body and
ii) alteration of drug by the body.
It includes absorption, distribution, biotransformation, and excretion (ADME) of drug from
the body.
2. Quantitative study of drug movements in, through and out of body.
3. It determines
i. Rout of drug administration
ii. Dose
iii. Onset of action
iv. Duration of action
v. Cmax
vi. Tmax
4. Biological Membrane
• Lipid bilayer
• 100 A0 thick
• Having hydrophilic (polar head) and
hydrophobic (non-polar tail ) end.
Polar group - glycerol phosphate + ethanol amine /
choline or hydroxyl group of cholesterol -
projected out side of the surface.
Hydrocarbon chain embedded
in the matrix.
5. Absorption
Site of administration → Systemic circulation.
Factors influence drug absorption:
a. Aqueous solubility of drug
Solid drug dissolution absorbed
Higher the water solubility higher the rate of absorption
Thus solution absorb faster rate then solid drugs.
b. Concentration.
c. Area of absorbing surface
d. Vascularity of the absorbing surface
e. Route of drug administration.
6. Mechanism of Absorption
Drugs are absorbed through the membrane either by
a. Passive diffusion and filtration or
b. Specialized transport
Passive diffusion:
Movement of drugs through membrane towards concentration gradient.
Lipid soluble drugs are diffused by dissolving in the lipoidal matrix of the membrane.
Such transfer is directly proportional to the magnitude of the concentration gradient across
the membrane, to the lipid–water partition coefficient of the drug, and to the membrane
surface area exposed to the drug.
After a steady state is attained, the concentration of the unbound drug is the same on both
sides of the membrane if the drug is a nonelectrolyte.
For ionic compounds, the steady-state concentrations depend on the electrochemical gradient
for the ion and on differences in pH across the membrane.
7. Mechanism of Absorption
Drug absorption are influenced by pH:
Most of the drugs are weak electrolyte (weak acids or bases) and their ionization is pH dependent.
However, strong electrolyte completely dissociates. The ionization of weak electrolyte are given by
the equation:
pH = pKa + log
This equation relates the pH of the medium around the drug and the drug’s acid dissociation
constant (pKa) to the ratio of the protonated (HA or BH+) and unprotonated (A– or B) forms, where
HA→ A– + H+ (Ka = [A–][H+]/[HA]) describes the dissociation of an acid, and BH+ → B + H+,
( Ka = [B][H+]/[BH+]) describes the dissociation of the pronated form of a base.
At steady state, an acidic drug will accumulate on the more basic side of the membrane and a basic
drug on the more acidic side—a phenomenon termed ion trapping.
[Protonated form]
[Unprotonated form]
8. Mechanism of Absorption
Thus weak acidic drug which is formed salt with strong cation are ionized at alkaline pH of
intestine and weak basic drugs are ionized at acidic pH of the stomach.
Acidic drug e.g. Aspirin remain unionized at acidic PH of stomach and absorbed from the
stomach area; while bases are largely absorbed from intestine.
Acidic drug which absorbed from the stomach to the gastric mucosal cell, revert to ionized
form within the cell (PH= 7 ) and only slowly passes to the extra cellular fluids
Basic drug is attained in high concentration intracellularly from intestine.
10. Mechanism of Absorption
Filtration:
Passage of drugs through aqueous pore in the membrane or through para cellular spaces. This
process can be accelerated if the hydrodynamic flow of solvent occur under osmotic pressure
gradients.
Lipid insoluble drugs cross through membrane by filtration if their molecular size is smaller
than the diameter of the pores.
Majority of the cell have very small pore size (4 A0) and drug with MW more than 100 –200, can
not penetrate through this pore. However, the capillaries of blood vessels ( except blood brain
barrier) have lager in (40 A0) size and most of the drug even albumin can diffuse through this
capillaries. The diffusion of drugs solely depend on the rate of blood flow.
11. Mechanism of Absorption
Special transport:
1. Carrier mediated 2. Pinocytosis
1. Carrier mediated:
Drug + Carrier = Drug-Carrier complex; then translocates.
Polar molecules (Hydrophilic) coated with hydrophobic layer thus facilitate transport.
Carrier transport is specific, saturable and competitively inhibited by the analogues which use the
same carrier.
2 types--
i) Active transport
ii) Facilitate diffusion.
12. Mechanism of Absorption
i) Active transport:
Against concentration gradation
Need energy and can be blocked by metabolic poisons
Selective accumulation occur
Natural metabolites are actively absorbed.
Primary Active Transport: Membrane transport that directly couples with ATP hydrolysis is called
primary active transport.
Secondary Active Transport: In secondary active transport, the transport across the plasma membrane
of one solute against its concentration gradient is driven energetically by the transport of another
solute in accordance with its concentration gradient.
14. Mechanism of Absorption
ii) Facilitate diffusion:
More rapid than simple diffusion, translocates even non-diffusible substrate but along the
concentration gradation.
Membrane transporters may facilitate diffusion of ions and organic compounds across the plasma
membrane; this facilitated diffusion does not require energy input.
Just as in passive diffusion, the transport of ionized and non-ionized compounds across the plasm
a membrane occurs down their electrochemical potential gradient.
2. Pinocytosis:
Process of transport of drug across the cells in particulate form
by forming vesicles.
Bigger molecules like protein are transported by this process.
15. Effect of route of administration on
drug absorption
Oral route
Subcutaneous route or intramuscular route
Topical route
Oral Route:
a) Effective barrier:
Epithelial lining (unionized lipid soluble drug- alcohol); rate of absorption is proportional to their
lipid : water partition co-efficient.
Acidic drug like aspirin, salicylates, barbiturate---- absorbed well from stomach,
Basic drug like morphine, atropine, quinine etc. absorb well form duodenum.
16. Effect of route of administration on
drug absorption
b) Even acidic drug absorption from stomach is less due to -
Thick mucus membrane
Small surface area
Slow dissolution
c) Presence of food:
Interfere absorption by
Dilution of drugs
Delay emptying
Drug-food interaction
d) Certain drugs degrade by the acidic environment of stomach e.g. Pen-G, Insulin, Cephalosporin etc.
Enteric coating or surface coating or other sustained release product free from such draw back.
17. Effect of route of administration on
drug absorption
e) Absorption also effected by drug-drug interaction.
Formation of complex -
Phenytion with sucralfate
Alkaloid with tannin containing preparation.
Can minimized by providing suitable gap between two drugs administration.
f) Effected by alteration of intestinal microbial flora
Enterohepatic circulation of oral contraceptives and digoxin.
g) Drugs also can alter GUT wall motility
e.g. Anticholinergic, tricyclic antidepressent, morphine, metaclopramid - relaxes gut wall.
Neomycin, Vinblastine, Methotraxate - damage the mucus membrane.
18. Effect of route of administration on
drug absorption
Subcutaneous:
Drug deposited directly into the vicinity of the capillaries. Lipid soluble drug directly passes across
the whole surface of the capillary membrane.
Capillaries are highly porous- do not obstruct ionized molecules, even large molecules are absorbed
through lymphatic system.
Drug those can not absorbed through oral route can absorbed through IM or SC
SC absorption is slower then IM
But both are faster than oral route.
Massage or application of heat accelerate the absorption
Addition of Vasoconstrictor- adrenaline retard absorption.
19. Effect of route of administration on
drug absorption
Topical site:
Depending on the lipid solubility of the drugs.
Only few drugs can penetrate through the intact skin, e.g. nitroglycerin, hyoscine, estradiol.
Corticosteroid- applied over skin can have systemic effect and pituitary adrenal suppression.
Absorption can be promoted by rubbing the skin, also incorporation of smoothening agent or
vasodilating agent enhance absorption.
Abrasive surface – accelerate the absorption process.
20. Bioavailability
Measured fraction of administrated dose of drug available into the systemic circulation in unchanged
form.
It refers to the rate and extent of absorption from a dosage form and determined by the concentration-
time curve.
Variation in bioavailability:
Reasons:
1. Route of administration: Bioavailability is 100% from i.v. route but frequently lower after oral
ingestion due to either incomplete absorption or fast pass metabolism. Incomplete absorption may
occur from S.C injection due to local tissue binding but usually less common.
21. Bioavailability
2.Variation in formulation:
Oral formulation of drug from different manufacturer or the same manufacturer of different batches
of chemically equivalent drug may not be biologically equivalent.
Biological equivalent: When two preparation of same drug are considered and the rate and extent of
absorption do not vary significantly at the given test condition, then those two drugs are considered to
be biologically equivalent.
3. Bioavailability depend on the rate and extent of disintegration and dissolution.
Before drug to be absorbed from oral dosages form they require to disintegrate, i.e. individual particle
must be detached from each other, and then dissolute and absorb.
Disintegration depends on type of additive materials used during preparation & force of compaction.
Dissolution depend on : i) Drug solubility ii)Particle size iii) Their crystal form and physical properties
22. Bioavailability
PlasmaConcentration(mg/ml)
Time (h)
AUC p.o.
F = ------------ x 100%
AUC i.v.
AUC –> Area Under The Curve
F –> Bioavailability
Difference in bioavailability seen with poorly soluble drugs. Reduction of particle size will enhance
drug solubility by increasing the surface area increase bioavailability reduces the dose size.
For e.g. the dosage of Griseofluvin and Spironolactone can be reduced to its half of the quantity
while given in micro fine powder form.
24. Distribution of Drugs
Once the drugs gain into the blood stream, it translocates to the other part where initially had no drugs
(movement according to concentration gradient).
Factor governing the distribution of drugs:
i. Lipid : water partition co-efficient of drug (lipid insoluble drug do not enter cell , so Vd is less)
ii. pKa value of drug (high pKa at physiological condition reduce the Vd)
iii. Degree of plasma protein bindings (reduce Vd)
iv. Affinity for different tissue (increase Vd)
v. Fat : lean body mass ratio (if ratio more Vd is less incase of electrolyte)
vi. Disease like CHF, uremia, cirrhosis (reduce Vd)
V = Volume of Distribution.
25. Volume of Distribution
Definition: Apparent Volume of distribution is defined as the volume that would accommodate all the
drugs in the body, if the concentration was the same as in plasma. Expressed in liters (L).
Vd =
Ex: Chloroquin – 13000 liters, Digoxin – 420 L, Morphine – 250 L and Propranolol – 280 L, Streptomycin
and Gentamicin – 18 L.
Why it is called apparent volume of distribution?
`Vd` is an imaginary Volume of Fluid which will accommodate the entire quantity of the drug in the
body, if the concentration throughout this imaginary volume were same as that in plasma.
Dose administered IV
Plasma concentration
27. Redistribution
Highly lipid soluble drug given I.V. or inhalation, initially rapidly get distributed to the organ
system with high blood flow e.g. brain, kidney, liver, heart etc. and then to the organ of less blood
flow or more bulky tissue e.g. muscles, fat, adipose tissue. Thus plasma concentration of drugs
gradually falls and slowly withdraw from high blood flow organ to bulky tissue.
Greater the lipid solubility of drug higher the rate of redistribution.
Brain and CSF Penetration
Blood brain barrier (BBB): Capillary endothelial cells of brain have tight junction and lack the entry
of larger molecules due to small intracellular pores. Further, an investment of neural covering (Glial
foot), gives the capillary more impermeable to large drugs. This capillary junction together with glial
foot constitute the so called blood brain barrier.
29. Brain and CSF Penetration
BBB is lipoidal and limits the entry of non-lipid soluble drugs (amikacin, gentamicin,
neostigmine etc.). Only lipid soluble unionized drugs penetrate and have action on the CNS.
Efflux carriers like P-gp (glycoprotein) present in brain capillary endothelial cell (also in intestinal
mucosal, renal tubular, hepatic canicular, placental and testicular cells) extrude drugs that enter
brain by other processes.
Inflammation of meninges of brain increases permeability of BBB.
Drug modification is required to target the brain. Dopamine (DA) does not enter brain, but its
precursor levodopa does. This is used latter in parkinsonism. (Reff: Goodman & Gilman’s Manual
of Pharmacology and Therapeutics – Treatment of CNS Degenerative Disorder).
30. Placental Transfer
Lipoidal in nature, thus allow free passage of lipophilic drugs and restrict only hydrophilic
drugs.
Placental P - glycoprotein serves to limit foetal exposure to maternally administrated drugs.
However, long time existence of non-lipid soluble drug at higher concentration in the maternal
circulation, restricted amount can penetrate into the placenta , and can cause harm to fetus.
Thus, it is incomplete barrier and almost any drug can cross and effect the fetus.
Plasma Protein Binding (PPB)
Most drugs possess physicochemical affinity for plasma proteins.
Acidic drugs bind to plasma albumin and basic drugs to α1-glycoprotein
Extent of binding depends on the individual compound.
Increasing concentration of drug can progressively saturate the binding sites
31. Plasma Protein Binding (PPB)
The clinical significance of PPB:
Highly PPB drugs are largely restricted to the vascular compartment and tend to have lower Vd.
The PPB fraction is not available for action.
There is an equilibration between PPB fraction of drug and free molecules of drug.
The drugs with high physicochemical affinity for plasma proteins (e.g. aspirin, sulfonamides,
chloramphenicol) can replace the other drugs (e.g. acenocoumarol, warfarin) or endogenous
compounds (bilirubin) with lower affinity.
High degree of protein binding makes the drug long acting, because bound fraction is not
available for metabolism, unless it is actively excreted by liver or kidney tubules.
Generally expressed plasma concentrations of the drug refer to bound as well as free drug.
In hypoalbuminemia, binding may be reduced and high concentration of free drug may be
attained (e.g. phenytoin).
32. Tissue Storage
Drug may accumulate in specific tissue or organs.
Drug tend to store different tissue contribute to long duration of action and larger V.
May cause local toxicity.
i. Heart and skeletal muscles – digoxin (to muscle proteins)
ii. Liver – chloroquine, tetracyclines, digoxin
iii. Kidney – digoxin, chloroquine
iv. Thyroid gland – iodine
v. Brain – chlorpromazine, isoniazid, acetazolamide
vi. Retina – chloroquine (to nucleoproteins)
vii. Iris – ephedrine, atropine (to melanin)
viii. Bones and teeth – tetracyclines, heavy metals (to mucopolysaccharide of connective tissue)
ix. Adipose tissues – thiopental, ether, minocycline, DDT.
33. Biotransformation
Metabolism of Drugs
What is Biotransformation?
Chemical alteration of the drug in the body
Aim: to convert non-polar lipid soluble compounds to polar lipid insoluble compounds
to avoid reabsorption in renal tubules
Most hydrophilic drugs are less biotransformed and excreted unchanged –
streptomycin, neostigmine and pancuronium etc.
Biotransformation is required for protection of body from toxic metabolites
Primary site of biotransformation are kidney, liver , intestine, lung and plasma.
34. Results of Biotransformation
1. Active drug and its metabolite to inactive metabolites – most drugs
(ibuprofen, paracetamol, chlormphenicol etc.)
2. Active drug to active product
(phenacetin – acetminophen or paracetamol,
morphine to Morphine-6-glucoronide,
digitoxin to digoxin etc.)
3. Inactive drug to active/enhanced activity (prodrug) –
levodopa - carbidopa,
prednisone – prednisolone
enlpril – enlprilat)
4. No toxic or less toxic drug to toxic metabolites (Isonizide to Acetyl isoniazide)
35. Biotransformation
2 (two) Phases of Biotransformation:
Phase I or Non-synthetic – metabolite may be
active or inactive
Phase II or Synthetic – metabolites are
inactive (Morphine – M-6 glucouronide is
exception)
36. Phase I - Oxidation
Most important drug metabolizing reaction – addition of oxygen or (– ve) charged
radical or removal of hydrogen or (+ ve) charged radical
Various oxidation reactions are – oxygenation or hydroxylation of C-, N- or S-atoms;
N or o – dealkylation
Involve – cytochrome P-450 monooxygenases (CYP), NADPH and Oxygen
More than 100 cytochrome P-450 isoenzymes are identified
In human - only 3 isoenzyme families important – CYP1, CYP2 and CYP3
Examples – Barbiturates, phenothiazines, paracetamol and steroids
37. Phase I - Reduction
This reaction is conversed of oxidation and involves CYP 450 enzymes working in the
opposite direction.
Examples - Chloramphenicol, levodopa, halothane and warfarin
Phase I - Hydrolysis
This is cleavage of drug molecule by taking up of a molecule of water. Similarly
amides and polypeptides are hydrolyzed by amidase and peptidases. Hydrolysis
occurs in liver, intestines, plasma and other tissues.
Examples - Choline esters, procaine, lidocaine, pethidine, oxytocin
Cyclization (formation of ring structure) Decyclization (opening up of ring structure)
38. Phase II Metabolism
Glucuronide conjugation: Compounds with hydroxyl or carboxylic acid group are
easily conjugated with glucuronic acid - derived from glucose
Examples: Chloramphenicol, aspirin, morphine, metronidazole, bilirubin, thyroxine.
Acetylation: Compounds having amino or hydrazine residues are conjugated with the
help of acetyl CoA, e. g. sulfonamides, isoniazid.
Sulfate conjugation: The phenolic compounds and steroids are sulfated by
sulfokinases, e.g. chloramphenicol, adrenal and other steroids.
Methylation: The amines and phenols can be methylated. Methionine and cysteine act
as methyl donors. Examples: adrenaline, histamine, nicotinic acid.
Ribonucleoside/nucleotide synthesis: Activation of many purine and pyrimidine
antimetabolites used in cancer chemotherapy
39. Drug Metabolizing Enzymes
Micrisomal enzymes:
Located into the smooth
endoplasmic reticulam
(microtubules) of liver, lung,
kidney, intestinal mucosa
Ex- monooxygenase, cyt-
P450, glucuronyl transferase.
They carry out most of the
oxidation, reduction,
hydrolysis and glucuronide
conjugation.
Non- microsomal enzymes:
They present in the cytoplasm ,
mitochondria especially in
hepatic cell and other tissue ,
even in plasma.
Ex. Flavoprotein oxidases,
esterases
Reaction catalyze by them are
some oxidation, many
hydrolytic reaction and all most
all conjugation reaction
40. Excretion
Out passage of systemically absorbed drug through excretion organ or secretion organ.
Routes of drug excretion
Urine:
Most important channel of excretion for most of the drug. Excrete through kidney
Faeces:
Unabsorbed fraction are excreted.
Drug is absorbed glucuronidated or sulfatated in the liver and secreted through the
bile glucuronic acid/sulfate is cleaved off by bacteria in GI tract drug is reabsorbed
(steroid hormones, rifampicin, amoxycillin, contraceptives)and excreted through urine.
Anthraquinone, heavy metals directly excreted in colon.
41. Routes of drug excretion
Exhale air:
Gases and volatile liquid- eliminate through lung, irrespective of their lipid solubility.
Ex- general anesthetics, paraldehyde, alcohol etc.
Exhale air:
Gases and volatile liquid- eliminate through lung , irrespective of their lipid solubility.
Ex- general anesthetics, paraldehyde, alcohol etc.
Milk:
Most of the lipid soluble and less protein bound drugs cross better into the breast milk.
Milk has lower pH (7) than plasma thus basic drug concentrated more in it. However the
total amount of drug excrete through breast milk is very minute quantity, thus causing
without any ill effect to the suckling infant.
42. Renal Excretion
Glomerular Filtration:
Normal GFR – 120 ml/min
Glomerular capillaries have pores larger than usual
The kidney is responsible for excreting all water soluble substances
All non-protein bound drugs (lipid soluble or insoluble) presented to the glomerulus are
filtered
Glomerular filtration of drugs depends on their plasma protein binding and renal blood
flow - Protein bound drugs are not filtered !
43. Renal Excretion
Tubular Reabsorption:
1. Depend on a) lipid solubility b) ionization of drug at urinary pH.
a) Lipid soluble drug - filtered at Glomerulus and 99% diffuse back into the tubules.
b) Lipid insoluble drugs can not be reabsorbed. Ex- Amino glycosides, Quaternary
ammonium compound etc.
2. Change in urinary pH effects tubular reabsorption
a) Weak base ionize more in acidic media and less reabsorbed.
b) Weak acid more ionize in alkaline media and are less reabsorbed
44. Renal Excretion
Tubular Secretion:
Energy dependent active transport of drug through the renal tubule – reduces the free
concentration of drugs – further, more drug dissociation from plasma binding – again more
secretion.
– organic acid transport
– organic base transport.
46. Kinetics of Elimination
Pharmacokinetics - F, V and CL
Clearance: The clearance (CL) of a drug is the theoretical volume of plasma from which
drug is completely removed in unit time.
CL = Rate of elimination (RoE)/C
Example = If a drug has 20 mcg/ml conc. and Rate of Elimination is 100 mcg/min
CL = 100/20 = 5 ml /min.
First Order Kinetics (exponential): Rate of elimination is directly proportional to drug
concentration, CL remaining constant.
Constant fraction of drug is eliminated per unit time.
Zero Order kinetics (linear): The rate of elimination remains constant irrespective of drug
concentration
CL decreases with increase in concentration.
47. Kinetics of Elimination
Pharmacokinetics - F, V and CL
Plasma half-life:
Defined as time taken for its plasma concentration to be reduced to half of its original value.
T 1/2 = In 2 / k
In 2 = 0.693
k = elimination rate constant = CL / V
T 1/2 = 0.693 x V / CL
1 half-life …………. 50%
2 half-lives………… 25%
3 half-lives …….…..12.5%
4 half-lives ………… 6.25%
50 + 25 + 12.5 + 6.25 + 3.125 = 97% drug is eliminated after 5 Half Lives.
CL = RoE/C
V = dose IV/C
48. Kinetics of Elimination
Loading Dose:
A single or few repeated or series of doses that may be given at the very beginning of the
therapy to reach the desire plasma concentration rapidly.
LD= Target Cp x V / Fraction of dose(F)
Thus, loading dose govern by V and fraction of dose. Plasma clearance (CL) or plasma half
life do not have any influence on Loading dose.
Maintenance Dose:
It is the amount of drug require to give in each intervals to replace the drug eliminated at
that particular interval since the preceding dose require to maintain a steady state of drug
always in the body.
Maintenance dose = dosing rate x dosing interval
Dosing rate = Target Cp x CL.